Salesforce AI Push With Cimulate Faces Valuation Question And Culture Risks

Simply Wall St

Sat, February 14, 2026 at 10:13 AM GMT+9 2 min read

In this article:

CRM

+2.31%

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

Salesforce (NYSE:CRM) has agreed to acquire AI startup Cimulate to support its AI powered commerce efforts.

More than 1,400 employees have signed a letter urging the company to end contracts with U.S. Immigration and Customs Enforcement.

The developments come alongside nearly 1,000 recent job cuts and a wide ranging leadership reshuffle.

For you as an investor watching NYSE:CRM, this mix of product expansion and internal pushback arrives at a time when large software providers are racing to embed AI across sales, service and commerce tools. AI focused acquisitions like Cimulate fit squarely into Salesforce’s core business of customer relationship management and cloud based enterprise applications, where automation and personalization are increasingly central to how clients run digital operations.

At the same time, the ICE controversy, workforce reductions and leadership changes put culture, execution risk and reputational exposure on the table alongside product plans. As this develops, many investors will be weighing how these cross currents could influence Salesforce’s ability to retain talent, win new enterprise deals and keep large customers comfortable with how the company pursues government and AI related work.

Stay updated on the most important news stories for Salesforce by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Salesforce.

NYSE:CRM Earnings & Revenue Growth as at Feb 2026

4 things going right for Salesforce that this headline doesn’t cover.

Quick Assessment

**✅ Price vs Analyst Target**: At US$189.72, Salesforce trades about 42% below the average analyst target of roughly US$327.

**✅ Simply Wall St Valuation**: Currently assessed as trading 42.5% below estimated fair value, which points to an undervalued setup.

**❌ Recent Momentum**: The 30 day return of about 20.8% decline shows weak short term sentiment.

There is only one way to know the right time to buy, sell or hold Salesforce. Head to the Simply Wall St’s company report for the latest analysis of Salesforce’s Fair Value.

Key Considerations

📊 The Cimulate deal keeps Salesforce tightly aligned with AI driven CRM and commerce, while internal unrest and job cuts test the company’s culture and execution.

📊 Watch how the US$189.72 share price, P/E of about 24.6 and analyst target range of US$223 to US$475 evolve as the integration of Cimulate and leadership reshuffle play out.

⚠️ The most immediate risk is reputational, as any public fallout over ICE related work or staff morale could influence large enterprise customers evaluating long term contracts.

 






繼續閱讀  

Dig Deeper

For the full picture including more risks and rewards, check out the complete Salesforce analysis. Alternatively, you can check out the community page for Salesforce to see how other investors believe this latest news will impact the company’s narrative.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include CRM.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

條款 及 私隱政策

Privacy Dashboard

More Info